Cargando…

Autologous stem cell transplantation in two children with disabling pansclerotic morphea

Detalles Bibliográficos
Autores principales:	Moll, M, Holzer, U, Zimmer, C, Rieber, N, Kuemmerle-Deschner, JB
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194738/ http://dx.doi.org/10.1186/1546-0096-9-S1-P77

Ejemplares similares

Disabling pansclerotic morphea of childhood – unusual case and management challenges
por: Ana-Maria, Forsea, et al.
Publicado: (2008)

Adult-Onset Unilateral Disabling Pansclerotic Morphea
por: Singh, Adarshlata, et al.
Publicado: (2014)

Disabling Pansclerotic Morphea of Childhood with Extracutaneous Manifestations
por: Kura, Mahendra M, et al.
Publicado: (2013)

Successful autologous stem cell transplantation (ASCT) in a patient with juvenile dermatomyositis
por: Holzer, U, et al.
Publicado: (2008)

A refractory heterogeneous Cryopyrin-Associated Periodic Syndrome (CAPS) phenotype related to V198M mutation responds to canakinumab - a case report
por: Hansmann, Sandra, et al.
Publicado: (2011)

Pansclerotic morphea: A male child with hemiatrophy of lower limb
por: Dasgupta, Malay K., et al.
Publicado: (2014)

Hyaluronidase injections for treatment of symptomatic pansclerotic morphea-induced microstomia
por: Abbas, Laila F., et al.
Publicado: (2019)

Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts
por: Ventéjou, Sarah, et al.
Publicado: (2021)

Pansclerotic morphea is characterized by IFN-γ responses priming dendritic cell fibroblast crosstalk to promote fibrosis
por: Xing, Enze, et al.
Publicado: (2023)

IL-1 inhibition in Muckle-Wells-Syndrome: withdrawal resulting in rapid deterioration of hearing loss
por: Hansmann, S, et al.
Publicado: (2015)

Childhood morphea does not impair self-perception
por: Carlomagno, R, et al.
Publicado: (2011)

Determinants of health-related quality of life in children and adults with autoinflammatory diseases
por: Erbis, G, et al.
Publicado: (2015)

The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885)
por: Wittkowski, H, et al.
Publicado: (2008)

Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
por: Tzaribachev, N, et al.
Publicado: (2008)

β-Confident-registry: aiming to be largest-ever studied cohort of cryopyrin-associated periodic syndromes (CAPS) patients. Study design and baseline characteristics
por: Kuemmerle-Deschner, J, et al.
Publicado: (2011)

NLRP3 Q703K and TNFRSF1A R92Q mutations in a patient with auto inflammatory disease
por: von Mühlenen, I, et al.
Publicado: (2015)

Pansclerotic Morphea Following COVID-19: A Case Report and Review of Literature on Rheumatologic and Non-rheumatologic Dermatologic Immune-Mediated Disorders Induced by SARS-CoV-2
por: Lotfi, Zahra, et al.
Publicado: (2021)

Unmet psychosocial needs in CAPS
por: Erbis, G, et al.
Publicado: (2015)

A functional inflammasome activation assay discriminates between genetically proven caps patients and patients with low penetrance NLRP3 variants
por: Rieber, Nikolaus, et al.
Publicado: (2014)

Long-term immune reconstitution after autologous stem-cell transplantation for severe autoimmune diseases
por: Alexander, T, et al.
Publicado: (2005)

Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab
por: Brogan, P, et al.
Publicado: (2015)

Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)
por: Horneff, G, et al.
Publicado: (2008)

Autologous stem cell transplantation in autoimmune arthritis restores immune homeostasis by renewal of the natural Treg compartment
por: van den Broek, T, et al.
Publicado: (2011)

PReS-FINAL-2122: Autologous stem cell transplantation in a patient with severe systemic sclerosis in Portugal
por: Guedes, M, et al.
Publicado: (2013)

PReS-FINAL-2336: Induction of MDSCS in Muckle-Wells syndrome
por: Rieber, N, et al.
Publicado: (2013)

Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: results from beta-confident registry
por: Kuemmerle-Deschner, J, et al.
Publicado: (2015)

PReS-FINAL-2125: A Japanese girl with childhood-onset anti-Ku antibody positive generalized morphea-myositis overlap syndrome
por: Kishi, T, et al.
Publicado: (2013)

Delayed diagnosis of Muckle-Wells syndrome – analysis of influencing factors
por: Kuemmerle-Deschner, Jasmin B, et al.
Publicado: (2012)

PReS-FINAL-2331: Low-penetrance NLRP3 variants
por: Endres, T, et al.
Publicado: (2013)

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab
por: Horneff, G, et al.
Publicado: (2011)

Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients
por: Bader-Meunier, B, et al.
Publicado: (2011)

PReS-FINAL-2329: Validation of the autoinflammatory activity index (AIDAI)
por: Piram, M, et al.
Publicado: (2013)

Development of the autoinflammatory disease damage index (ADDI)
por: Annink, K, et al.
Publicado: (2015)

Canakinumab treat-to target strategies increase complete response rate in CAPS
por: Kuemmerle-Deschner, J, et al.
Publicado: (2015)

Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B positive patients with hepatocellular carcinoma
por: Bayer, Michael, et al.
Publicado: (2014)

P1279: OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA WITH TWO OR MORE HIGH-RISK CYTOGENETIC ABNORMALITIES
por: Pasvolsky, Oren, et al.
Publicado: (2023)

Dermoscopy of Morphea
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2019)

P1328: SUCCESFUL TREATMENT OF GRAFT FAILURE IN AUTOLOGOUS STEM CELL TRANSPLANTATION WITH CYCLOSPORINE
por: Cubillas, D., et al.
Publicado: (2022)

Establishment of juvenile and tolerant immune systems in patients with autoimmune diseases treated with immunoablation and autologous stem cell therapy
por: Radbruch, A, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_phjl703vctqt9qb39ajr467086